Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease (E-HART)

NCT03062176 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT03062176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03062176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease (E-HART)
Lead sponsor
Virginia Commonwealth University
Phase
Phase 2
Overall status
Withdrawn
Start date
April 3, 2017
Completion date
May 15, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, heart failure, systolic, renal disease, end stage